{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:42:59Z","timestamp":1791434579983,"version":"4.3.3"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>This study characterizes the changes in the pharmacokinetics of phenobarbital associated with extracorporeal membrane oxygenation treatment in neonates, to illustrate our findings and provide guidance on dosing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Retrospective pilot population pharmacokinetic analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Neonatal ICU.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Thirteen critically ill neonates (birth body weight, 3.21\u2009kg [2.65\u20133.72 kg]; postnatal age at start of treatment: 2 d [0\u20137 d]; gestational age: 38\u2009wk [38\u201341 wk]) receiving venovenous or venoarterial extracorporeal membrane oxygenation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Phenobarbital administered in a loading dose of 7.5\u2009mg\/kg (8.5\u201316\u2009mg\/kg) and maintenance dose of 6.9\u2009mg\/kg\/d (4.5\u20138.5\u2009mg\/kg\/d).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Therapeutic drug monitoring data were available, yielding 5, 31, and 19 phenobarbital concentrations before, during, and after extracorporeal membrane oxygenation, respectively. Population pharmacokinetic analysis was performed using NONMEM 7.3.0 (ICON Development Solutions, Ellicott City, MD). Maturation functions for clearance and volume of distribution were obtained from literature. In a one-compartment model, clearance and volume of distribution for a typical neonate off extracorporeal membrane oxygenation and with a median birth body weight (3.21\u2009kg) at median postnatal age (2 d) were 0.0096\u2009L\/hr (relative <jats:sc>se<\/jats:sc> = 11%)) and 2.72\u2009L (16%), respectively. During extracorporeal membrane oxygenation, clearance was found to linearly increase with time. Upon decannulation, phenobarbital clearance initially decreased and subsequently increased slowly driven by maturation. Extracorporeal membrane oxygenation-related changes in volume of distribution could not be identified, possibly due to sparse data collection shortly after extracorporeal membrane oxygenation start. According to the model, target attainment is achieved in the first 12 days of extracorporeal membrane oxygenation with a regimen of a loading dose of 20\u2009mg\/kg and a maintenance dose of 4\u2009mg\/kg\/d divided in two doses with an increase of 0.25\u2009mg\/kg every 12 hours during extracorporeal membrane oxygenation treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>We found a time-dependent increase in phenobarbital clearance during the first 12 days of extracorporeal membrane oxygenation treatment in neonates, which results in continuously decreasing phenobarbital exposure and increases the risk of therapeutic failure over time. Due to high unexplained variability, frequent and repeated therapeutic drug monitoring should be considered even with the model-derived regimen.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000002402","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T01:04:29Z","timestamp":1594170269000},"page":"e707-e715","source":"Crossref","is-referenced-by-count":12,"title":["Rapid Increase in Clearance of Phenobarbital in Neonates on Extracorporeal Membrane Oxygenation: A Pilot Retrospective Population Pharmacokinetic Analysis"],"prefix":"10.1097","volume":"21","author":[{"given":"Danica","family":"Michali\u010dkov\u00e1","sequence":"first","affiliation":[{"name":"Institute of Pharmacology, First Faculty of Medicine & General University Hospital, Charles University, Prague, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Pokorn\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"Tibboel","sequence":"additional","affiliation":[{"name":"Intensive Care and Department of Pediatric Surgery, Erasmus MC-Sophia Children\u2019s Hospital, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Slana\u0159","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, First Faculty of Medicine & General University Hospital, Charles University, Prague, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherijne A. J.","family":"Knibbe","sequence":"additional","affiliation":[{"name":"Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands."},{"name":"Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke H. J.","family":"Krekels","sequence":"additional","affiliation":[{"name":"Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2174\/138920012800840383","article-title":"Pharmacotherapy in neonatal and pediatric extracorporeal membrane oxygenation (ECMO).","volume":"13","author":"Wildschut","year":"2012","journal-title":"Curr Drug Metab"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"93","DOI":"10.21037\/acs.2018.11.03","article-title":"The Extracorporeal Life Support Organization Registry: Update and perspectives.","volume":"8","author":"Lorusso","year":"2019","journal-title":"Ann Cardiothorac Surg"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.pcl.2012.07.013","article-title":"The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children.","volume":"59","author":"Wildschut","year":"2012","journal-title":"Pediatr Clin North Am"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00134-010-2041-z","article-title":"Determinants of drug absorption in different ECMO circuits.","volume":"36","author":"Wildschut","year":"2010","journal-title":"Intensive Care Med"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/phar.1882","article-title":"Evaluation of altered drug pharmacokinetics in critically ill adults receiving extracorporeal membrane oxygenation.","volume":"37","author":"Ha","year":"2017","journal-title":"Pharmacotherapy"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"741.e9","DOI":"10.1016\/j.jcrc.2012.02.013","article-title":"Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation.","volume":"27","author":"Shekar","year":"2012","journal-title":"J Crit Care"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"S629","DOI":"10.21037\/jtd.2017.09.154","article-title":"Optimising drug dosing in patients receiving extracorporeal membrane oxygenation.","volume":"10","author":"Cheng","year":"2018","journal-title":"J Thorac Dis"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/bcp.12577","article-title":"Indications of newer and older anti-epileptic drug use: Findings from a southern Italian general practice setting from 2005-2011.","volume":"79","author":"Italiano","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/jcpt.12632","article-title":"Estimation of initial phenobarbital dosing in term neonates with moderate-to-severe hypoxic ischaemic encephalopathy following perinatal asphyxia.","volume":"43","author":"\u0160\u00edma","year":"2018","journal-title":"J Clin Pharm Ther"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"S513","DOI":"10.33549\/physiolres.933213","article-title":"Effect of co-medication on the pharmacokinetic parameters of phenobarbital in asphyxiated newborns.","volume":"64","author":"\u0160\u00edma","year":"2015","journal-title":"Physiol Res"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/WNL.31.8.1042","article-title":"Phenobarbital maintenance dose requirements in treating neonatal seizures.","volume":"31","author":"Fischer","year":"1981","journal-title":"Neurology"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/clinchem\/27.9.1575","article-title":"Fluorescence polarization immunoassay. iii. An automated system for therapeutic drug determination.","volume":"27","author":"Jolley","year":"1981","journal-title":"Clin Chem"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","article-title":"PsN-Toolkit\u2013a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.","volume":"79","author":"Lindbom","year":"2005","journal-title":"Comput Methods Programs Biomed"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cmpb.2003.11.003","article-title":"Perl-speaks-NONMEM (PsN)\u2013a Perl module for NONMEM related programming.","volume":"75","author":"Lindbom","year":"2004","journal-title":"Comput Methods Programs Biomed"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cmpb.2010.04.018","article-title":"Pira\u00f1a and PCluster: A modeling environment and cluster infrastructure for NONMEM.","volume":"101","author":"Keizer","year":"2011","journal-title":"Comput Methods Programs Biomed"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.ejps.2017.05.026","article-title":"Model-based clinical dose optimization for phenobarbital in neonates: An illustration of the importance of data sharing and external validation.","volume":"109S","author":"V\u00f6ller","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"R17-20230824","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","article-title":"Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R.","volume":"90","author":"Comets","year":"2008","journal-title":"Comput Methods Programs Biomed"},{"issue":"Suppl 1","key":"R19-20230824","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00228-009-0782-9","article-title":"The role of population PK-PD modelling in paediatric clinical research.","volume":"67","author":"De Cock","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13054-015-0891-z","article-title":"Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: Results from an ex vivo study.","volume":"19","author":"Shekar","year":"2015","journal-title":"Crit Care"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: A major update to the DrugBank database for 2018.","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"R22-20230824","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00007691-199308000-00001","article-title":"Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs.","volume":"15","author":"Dagan","year":"1993","journal-title":"Ther Drug Monit"},{"key":"R23-20230824","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/bcp.13235","article-title":"Population pharmacokinetics of intravenous clonidine for sedation during paediatric extracorporeal membrane oxygenation and continuous venovenous hemofiltration.","volume":"83","author":"Kleiber","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"R24-20230824","doi-asserted-by":"crossref","first-page":"S642","DOI":"10.21037\/jtd.2017.11.02","article-title":"Drugs pharmacokinetics during veno-venous extracorporeal membrane oxygenation in pediatrics.","volume":"10","author":"Di Nardo","year":"2018","journal-title":"J Thorac Dis"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000002402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:11:49Z","timestamp":1692839509000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000002402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000002402","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,26]]}}}